CoChat

The Alzheimer Precision Medicine Initiative

Hampel, Harald, Alzheimer Precision Medicine Initiative (APMI) AGUILARLisi Flores (Montréal) BABILONIClaudio(Rome) BALDACCIFilippo(Pisa) BENDANorbert(Bonn) BLACKKeith L.(Los Angeles) BOKDEArun L.W.(Dublin) BONUCCELLIUbaldo(Pisa) BROICHKarl(Bonn) CACCIOLAFrancesco(Siena) CASTRILLO†Juan(Derio) CAVEDOEnrica(Paris) CERAVOLORoberto(Pisa) CHIESAPatrizia A.(Paris) CORVOLJean-Christophe(Paris) CUELLOAugusto Claudio(Montréal) CUMMINGSJeffrey L.(Las Vegas) DEPYPEREHerman(Gent) DUBOISBruno(Paris) DUGGENTOAndrea(Rome) ESCOTT-PRICEVal, Vergallo, Andrea, Perry, George, Lista, Simone · 2019 · Journal of Alzheimer's Disease
Cited by 103

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Precision medicine (PM) is an evolving scientific renaissance movement implementing key breakthrough technological and scientific advances to overcome the limitations of traditional symptom- and sign-based phenotypic diagnoses and clinical “one-size-fits-all, magic bullet drug development” in these largely heterogeneous target populations. It is a conceptual shift from ineffective treatments for biologically heterogeneous “population averages” to individually-tailored biomarker-guided targeted therapies. PM is defining which therapeutic approach will be the most effective for a specific individual, at a determined disease stage, across multiple medical research fields, including neuroscience, neurology and psychiatry. The launch of the Alzheimer Precision Medicine Initiative (APMI) and its associated cohort program in 2016—facilitated by the academic core coordinating center run by the Sorbonne University Clinical Research Group in Alzheimer Precision Medicine (Sorbonne University GRC n°21 APM)”—is geared at transforming healthcare, conventional clinical diagnostics, and drug development research in Alzheimer’s disease. Ever since the commencement of the APMI, the international interdisciplinary research network has introduced groundbreaking translational neuroscience programs on the basis of agnostic exploratory genomics, systems biology, and systems neurophysiology applying innovative “big data science”, including breakthrough artificial intelligence-based algorithms. Here, we present the scientific breakthrough advances and the pillars of the theoretical and conceptual development leading to the APMI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jad-181121

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 103

Metadata

Authors
Hampel, H., ESCOTT-PRICEVal, A. P. M. I. (. A. F. (. B. B. B. B. L. (. A. B. L. W. (. B. B. C. C. C. C. C. A. (. C.-C. C. C. C. L. (. V. D. D. D., Vergallo, A., Perry, G., & Lista, S.
Venue
Journal of Alzheimer's Disease
Published
2019-03-12
Volume
68
Issue
1
Pages
1-24
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W2915118821
Cited by
103
References
22
FWCI
10.37
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.